Castle Biosciences, Inc. (CSTL)
33.47
-0.73
(-2.13%)
USD |
NASDAQ |
Aug 24, 16:00
33.50
+0.03
(+0.09%)
After-Hours: 20:00
Castle Biosciences Gross Profit Margin (Quarterly) : 74.29% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 74.29% |
| March 31, 2026 | 72.15% |
| December 31, 2025 | 75.87% |
| September 30, 2025 | 74.09% |
| June 30, 2025 | 76.64% |
| March 31, 2025 | 48.58% |
| December 31, 2024 | 75.60% |
| September 30, 2024 | 78.57% |
| June 30, 2024 | 80.20% |
| March 31, 2024 | 77.28% |
| December 31, 2023 | 77.17% |
| September 30, 2023 | 77.25% |
| June 30, 2023 | 72.69% |
| March 31, 2023 | 69.60% |
| December 31, 2022 | 68.42% |
| September 30, 2022 | 68.89% |
| June 30, 2022 | 70.93% |
| Date | Value |
|---|---|
| March 31, 2022 | 70.48% |
| December 31, 2021 | 76.42% |
| September 30, 2021 | 76.70% |
| June 30, 2021 | 81.46% |
| March 31, 2021 | 86.15% |
| December 31, 2020 | 84.29% |
| September 30, 2020 | 83.51% |
| June 30, 2020 | 82.90% |
| March 31, 2020 | 86.13% |
| December 31, 2019 | 88.45% |
| September 30, 2019 | 88.29% |
| June 30, 2019 | 81.07% |
| March 31, 2019 | 81.25% |
| September 30, 2018 | 63.07% |
| June 30, 2018 | 65.61% |
| March 31, 2018 | 64.63% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| RadNet, Inc. | 7.89% |
| Lumexa Imaging Holdings, Inc. | 10.90% |
| Labcorp Holdings, Inc. | 27.71% |
| Quest Diagnostics, Inc. | 32.53% |
| OPKO Health, Inc. | 37.32% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -4.18% |
| Return on Assets | -3.44% |
| Return on Invested Capital | -3.87% |
| Profit Margin (Quarterly) | -1.99% |
| Operating Margin (Quarterly) | -2.96% |
| Return on Net Operating Assets | -7.36% |